Latest News

MSCA 2017 Presidency conference ‘Mobility takes research further’

13 March 2017

Read more ...

aDDRess and CodeAge Final ITN Conference: Abstract book now online!

03 November 2016

Read more ...

Björn Schumacher presentation on BR alpha Campus

7 October 2016

Read more ...


gallery prev2

(Click image to open the gallery)


Let us hear from you.
This email address is being protected from spambots. You need JavaScript enabled to view it. or complete our contact form.

Thanks to


Prof. Dr. Nektarios Tavernarakis
Institute of Molecular Biology and Biotechnology - FORTH, Greece


Institute of Molecular Biology and Biotechnology - FORTH
Foundation for Research and Technology-Hellas
Nikolaou Plastira 100, Vasilika Vouton

70013 Heraklion, Greece
Tel: +30 281 0391069


Nektarios Tavernarakis holds a Research Director (Professor) position at the Institute of Molecular Biology and Biotechnology, in Heraklion, Crete, Greece, heading the Neurogenetics and Ageing laboratory. He is also an elected Excellence Professor of Molecular Systems Biology at the Medical School of the University of Crete. He earned his Ph.D. degree at the University of Crete, studying gene expression in yeast, and trained in Caenorhabditis elegans genetics and molecular biology at Rutgers University, New Jersey, USA. He is the recipient of a European Research Council (ERC) Advanced Investigator grant award, a European Molecular Biology Organisation (EMBO) Young Investigator award, an International Human Frontier in Science Program Organization (HFSPO) long-term award, the Bodossaki Foundation Scientific Prize for Medicine and Biology, the Alexander von Humboldt Foundation, Friedrich Wilhelm Bessel research award, and is member of EMBO.

Research interests:

The main interests of the Tavernarakis laboratory focus on the molecular mechanisms of necrotic cell death in neurodegeneration and senescent decline, the molecular mechanisms of sensory transduction and integration by the nervous system, the interplay between cellular metabolism and ageing, and the development of novel genetic tools for C. elegans research.